Nutriband (NTRB) Price & Analysis

Compare

143 Followers

NTRB Stock Chart & Stats

$4.42

-$0.10(-2.25%)

At close: Jan 08 4:00 PM EST

$4.42

-$0.10(-2.25%)

Day’s Range― - ―

52-Week Range$4.17 - $11.68

Previous CloseN/A

Volume13.23K

Average Volume (3M)31.62K

Market Cap

$51.87M

Enterprise Value$47.01M

Total Cash (Recent Filing)$5.31M

Total Debt (Recent Filing)$216.42K

Price to Earnings (P/E)―

Beta1.57

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding12,174,883

10 Day Avg. Volume33,995

30 Day Avg. Volume31,617

Financial Highlights & Ratios

PEG Ratio-0.19

Price to Book (P/B)13.68

Price to Sales (P/S)41.09

P/FCF Ratio-18.63

Enterprise Value/Market Cap0.91

Enterprise Value/Revenue20.63

Enterprise Value/Gross Profit63.23

Enterprise Value/Ebitda-3.75

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Market GrowthThe additional safety from the abuse-deterrent technology could potentially grow the market and drive upward revisions to estimates.

PartnershipsNutriband has a partnership with Kindeva Drug Delivery, formerly part of 3M, to add the AVERSA technology to Kindeva’s transdermal fentanyl patch.

Product DevelopmentThe AVERSA Fentanyl patch could prevent abuse and accidental misuse of fentanyl transdermal patches.

Bears Say

Development CostsNutriband and its partner, Kindeva, have amended their development and commercialization agreement covering AVERSA Fentanyl, the abuse-deterrent transdermal fentanyl patch in development.

Nutriband News

Nutriband provides summary of annual shareholder meeting

Nutriband (NTRB) has provided an update to shareholders on the key milestones and discussions from this years Annual...

13d ago

NTRB

Nutriband shareholders approve proposals and expand board leadership

Nutriband ( ($NTRB) ) has provided an update. Nutriband held its 2026 Annual Meeting of Stockholders on January...

9d ago

NTRB

Nutriband says ‘committed’ to shareholder value as ‘number one focus’

Nutriband (NTRB) announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and...

1M ago

NTRB

Nutriband Divests Pocono Stake to Fund AVERSA Fentanyl

An announcement from Nutriband ( ($NTRB) ) is now available. On December 29, 2025, Nutriband Inc. announced that...

1M ago

NTRB

Nutriband to sell majority stake of Pocono Pharmaceutical for $5M

Nutriband (NTRB) signed an agreement to sell a 90% interest in its subsidiary Pocono Pharmaceutical for $5M to...

1M ago

NTRB

Trump Trade: Trump Media to merge with TAE Technologies

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

2M ago

DJT

SPY

Nutriband signs LOI with Qvanta Group of companies

Nutriband (NTRB) announced the signing of a non-binding Letter of Intent with the Qvanta Group of Companies. The...

2M ago

NTRB

Nutriband provides response to Trump’s Executive Order related to fentanyl

Nutriband (NTRB) provides the following response to the Trump Administration’s Executive Order designating illicit fentanyl and its core...

2M ago

NTRB

Nutriband Advances with FDA on Fentanyl Patch

Nutriband ( ($NTRB) ) has shared an update. Nutriband Inc. announced the successful completion of a meeting with...

4M ago

NTRB

Nutriband announces meeting completed with U.S. FDA for AVERSA FENTANYL

Nutriband (NTRB) announced that it has received final meeting minutes from its recent virtual face-to-face meeting held on...

4M ago

NTRB

Nutriband co-founder Gareth Sheridan returns as CEO

Nutriband (NTRB) announced that Company founder, Gareth Sheridan has returned as Company CEO. During the period of August...

4M ago

NTRB

Nutriband signs agreement with Brand Institute to develop brand for patch

Nutriband (NTRB) announced that through its 4P Therapeutics subsidiary, it has signed an agreement with Brand Institute to...

4M ago

NTRB

Nutriband files provisional patent application for AVERSA technology

Nutriband (NTRB) announced that it has filed a provisional patent application with the U.S. Patent and Trademark Office,...

4M ago

NTRB

Nutriband Issues Shares Amid Investor Engagement

Nutriband ( ($NTRB) ) has issued an announcement. Between February 1 and July 31, 2025, Nutriband saw the...

5M ago

NTRB

NTRB FAQ

What was Nutriband Inc’s price range in the past 12 months?

Nutriband Inc lowest stock price was $4.17 and its highest was $11.68 in the past 12 months.

What is Nutriband Inc’s market cap?

Nutriband Inc’s market cap is $51.87M.

When is Nutriband Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Nutriband Inc’s earnings last quarter?

Currently, no data Available

Is Nutriband Inc overvalued?

According to Wall Street analysts Nutriband Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Nutriband Inc pay dividends?

Nutriband Inc does not currently pay dividends.

What is Nutriband Inc’s EPS estimate?

Nutriband Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nutriband Inc have?

Nutriband Inc has 12,174,883 shares outstanding.

What happened to Nutriband Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Nutriband Inc?

Currently, no hedge funds are holding shares in NTRB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Nutriband Stock Smart Score

Neutral

Crowd Wisdom

Very Negative

Last 7 Days ▲ 2.4%
Last 30 Days ▼ 11.0%

Technicals

Fundamentals

Return on Equity

-98.00%

Trailing 12-Months

Asset Growth

-25.36%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Nutriband Inc

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.